News and Press Releases

Asymchem welcomes Franck Mevellec as senior director of Business Development

29 May 2024 -- Paris, France --  Asymchem, a leading global CDMO, is excited to announce the appointment of Franck Mevellec as senior director of business development. Franck brings over...

Category: BioManufacturing, Drug Discovery, Pharmaceutical
Posted: May 29, 2024

Asymchem Laboratories (Tianjin) Co., Ltd No. 6 Dongting 3rd Avenue, TEDA Tianjin, 300457, P.R. China

Generis Welcomes Max Kelleher as New Chief Executive Officer

14 May 2024 -- London, UK -- Generis, creator of the cloud data, content and business process management platform CARA, today announced that Max Kelleher will be stepping into the...

Category: Biotechnology, Other
Posted: May 14, 2024

Generis Technology Limited 239 Kensington High Street London W8 6SA

ERS Genomics appoints John E Milad as Chief Executive Officer

13 May 2024 -- Dublin, Ireland -- ERS Genomics, the CRISPR licensing company, today announced the appointment of John E Milad as CEO, with immediate effect. John brings over 25...

Category: Drug Delivery, Drug Discovery
Posted: May 13, 2024

8th Floor, Block E, Iveagh Court, Harcourt Road, Dublin D02 YT22, Ireland

Verisense Health Elects Josh Tolkoff to its Board of Directors

Josh brings extensive medical device, investment and growth management experience to his new role 9 May 2024 -- Massachusetts, US -- Verisense Health, a digital health technology and data company,...

Category: Biotechnology, Other
Posted: May 9, 2024

810 Memorial Dr, Suite 109 Cambridge, MA 02139 USA

Gilead Sciences Appoints Peter Wickersham to Vice-President and General Manager in the UK and Ireland

7 May 2024 -- London, UK -- Gilead Sciences announced today the appointment of Peter Wickersham as vice-president and general manager for the UK and Ireland. In his new role,...

Category: Drug Discovery, Pharmaceutical
Posted: May 7, 2024

Kindeva Drug Delivery Invests in Second Manufacturing Line for Greener Inhalers at UK Manufacturing Site

6 May 2024 -- Minnesota, US, and Missouri, US -- Kindeva Drug Delivery, a global leader in drug-device combination products, today announced its investment in a second manufacturing line for...

Category: Drug Delivery, Manufacturing and Packing
Posted: May 6, 2024

Barinthus Bio Names Experienced Physician, Leon Hooftman MD, as Chief Medical Officer 

Dr Hooftman brings more than 25 years’ experience in international drug development including immunology, autoimmunity, haematology, oncology and infectious diseases 1 May 2024 -- Oxford, UK -- Barinthus Biotherapeutics, formerly Vaccitech, a clinical-stage biopharmaceutical...

Category: BioManufacturing, Drug Discovery
Posted: May 1, 2024

Unit 6-10 Zeus Building Rutherford Avenue Harwell OX11 0DF

ProBioGen Announces Change in Management

30 April 2024 -- Berlin, Germany -- ProBioGen AG, a premier contract development and manufacturing organisation (CDMO) and technology provider with extensive expertise in cell line engineering, process development and GMP...

Category: BioManufacturing, Other
Posted: April 30, 2024

Herbert-Bayer-Straße 8 13086 Berlin

Sphere Fluidics appoints Dale Levitzke as Chief Executive Officer

Dale Levitzke joins as Dr Frank F Craig, current CEO and co-founder, announces his retirement after leading the company for 14 years 30 April 2024 -- Cambridge, UK -- Sphere...

Category: Biotechnology, Other
Posted: April 30, 2024

The Jonas Webb Building, Babraham Research Campus, Babraham, Cambridge CB22 3AT, United Kingdom

Calluna Pharma appoints Margrethe Sørgaard as Senior Vice President of Clinical Operations and Pharmacovigilance

First senior executive appointment made following Company launch to oversee strategic development of clinical programmes 23 April 2024 -- Oslo, Norway -- Calluna Pharma, a clinical stage company pioneering a...

Category: Other, Pharmaceutical
Posted: April 23, 2024

Nytt Foretak AS, Grundingen 6, 0250 Oslo, Norway.

G.ST Antivirals reports start of Phase 2 trial and announces appointment of Ronald Bruce Turner as new Chief Medical Officer

Phase 2 clinical trial started, first subject in on 2 April 2024 New CMO Ronald Bruce Turner MD, distinguished expert in the clinical research of rhinoviruses, to oversee trial and...

Category: Biotechnology, Clinical Trials
Posted: April 9, 2024

Dr. Bohr-Gasse 7 (VBC6) 1030 Vienna Austria

University of Liverpool to Use Touchlight’s Rapid Enzymatic dbDNA in Fully Personalised Neoantigen Cancer Vaccine Clinical Study

The UK’s Medical Research Council is funding a 10-patient phase 1 study to deliver rapid personalised treatment for lung cancer patients 3 April 2024 -- Hampton, UK -- Touchlight, a...

Category: Biotechnology, Clinical Trials
Posted: April 3, 2024

Morelands & Riverdale Buildings Lower Sunbury Road Hampton TW12 2ER

Touchlight Awarded Tender to Supply Enzymatic dbDNA to CPI’s RNA Centre of Excellence

28 March 2024 -- Hampton, UK -- Touchlight, an innovation-driven CDMO enabling the development of genetic medicines with its doggybone DNA (dbDNA) technology and leaders in enzymatic DNA production, is...

Category: Biotechnology
Posted: March 28, 2024

Morelands & Riverdale Buildings Lower Sunbury Road Hampton TW12 2ER

Recipharm attains major sustainability milestones

Approval of ambitious Greenhouse Gas emission reduction targets by SBTi Commitment to renewable electricity sourcing to 100.0% by 2024 and to 42.1% GHG emission reduction (Scope 1 and 2) by...

Category: Manufacturing and Packing
Posted: March 26, 2024

Gilbert To Officially Open New Development and GMP Manufacturing Facility

22 March 2024 -- Nottingham, UK -- UK-based contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions was joined by Oxford/AstraZeneca COVID-19 vaccine co-inventor Professor Dame Sarah Gilbert, biotech industry representatives and...

Category: BioManufacturing, Clinical Trials, Manufacturing and Packing
Posted: March 22, 2024

Albert Einstein Centre, Nottingham Science Park, Nottingham, UK, NG7 2TN